$0.00020
At close: Apr 24, 3:06 PM EDT
$0.00010
-0.00010-50.00%
After Hours: Dec 23, 4:05 PM EDT
Comments
Loading...
Navidea Biopharmaceutical Earnings Estimates, EPS & Revenue | OTC:NAVB | Benzinga
Navidea Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$610.00
Analyze the earnings history of Navidea Biopharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceutical | -$0.25 | — | -$0.02 | — | $7.52K | — | $0.00 | — | 11/14/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.10 | — | -$0.03 | — | $57.53K | — | $0.00 | — | 08/11/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.10 | — | -$0.09 | — | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.12 | — | -$0.11 | — | $50.35K | — | $610.00 | — | 03/21/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.08 | — | -$0.25 | — | $96.38K | — | $7.52K | — | 11/14/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.09 | — | -$0.10 | — | $261.05K | — | $57.53K | — | 08/15/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.11 | — | -$0.10 | — | $123.74K | — | $0.00 | — | 05/12/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.11 | — | -$0.12 | — | $219.25K | — | $50.35K | — | 03/23/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.13 | -$0.11 | -$0.08 | 27.27% | $268.39K | — | $96.38K | — | 11/10/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.11 | -$0.08 | -$0.09 | -12.50% | $271.10K | — | $261.05K | — | 08/11/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.13 | -$0.08 | -$0.12 | -50.00% | $156.27K | — | $123.74K | — | 05/11/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.15 | -$0.12 | -$0.11 | 8.33% | $119.30K | $600.00K | $219.25K | -63.46% | 03/24/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.17 | -$0.09 | -$0.13 | -44.44% | $236.81K | $150.00K | $268.39K | 78.93% | 11/12/2020 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.24 | — | -$0.11 | — | $260.09K | $156.00K | $271.10K | 73.78% | 08/13/2020 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.24 | — | -$0.13 | — | $136.03K | — | $156.27K | — | 05/14/2020 | Get Alert |
Navidea Biopharmaceutical (NAVB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-10 | $-0.08 | $-0.11 | 27.3 % |
| Q2 | 2021-08-11 | $-0.09 | $-0.08 | -12.5 % |
| Q1 | 2021-05-11 | $-0.12 | $-0.08 | -50.0 % |
| Q4 | 2021-03-24 | $-0.11 | $-0.12 | 8.33 % |
Navidea Biopharmaceutical (NAVB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2021-03-24 | $219.25K | $600.00K | -63.5 % |
| Q3 | 2020-11-12 | $268.39K | $150.00K | 78.9 % |
| Q2 | 2020-08-13 | $271.10K | $156.00K | 73.8 % |
FAQ
When is Navidea Biopharmaceutical (OTCEM:NAVB) reporting earnings?
Navidea Biopharmaceutical (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Navidea Biopharmaceutical (OTCEM:NAVB)?
Navidea Biopharmaceutical (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was $-0.02, which missed the estimate of $0.00.
What were Navidea Biopharmaceutical’s (OTCEM:NAVB) revenues?
Navidea Biopharmaceutical (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
